Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes

Clinical trial NCT05193578 · COMPLETED

Trial details

NCT number: NCT05193578
Sponsor: Jan Frystyk
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Prediabetic State

Start date: 2022-01-01
Primary completion: 2024-03-18
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.